Pharmacokinetics of Orally Inhaled Drug Products
Open Access
- 12 March 2015
- journal article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 17 (3), 769-775
- https://doi.org/10.1208/s12248-015-9736-6
Abstract
The presentations at the Orlando Inhalation Conference on pharmacokinetic (PK) studies indicated that PK is the most sensitive methodology for detecting formulation differences of oral inhaled drug products (OIDPs) that have negligible gastrointestinal bioavailability or for which oral absorption can be prevented (e.g., ingestion of charcoal). PK studies, therefore, may represent the most appropriate methodology for assessing local and systemic bioequivalence (BE). It was believed by many (but not all participants) that potential differences between formulations are more likely to be detected in healthy adult volunteers, as variability is reduced while deposition to peripheral areas is not restricted. A study design allowing assessment and statistical consideration of intra-subject and inter-batch variability within the evaluation of BE studies was suggested, while optimal inhalation technique during PK studies should be enforced to decrease variability. Depending on the drug and in vitro method, in vitro tests may not detect differences in PK parameters. Harmonization of BE testing requirements among different countries should be encouraged to improve global availability of low cost OIDPs and decrease industry burden.Keywords
This publication has 10 references indexed in Scilit:
- Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug AdministrationThe AAPS Journal, 2012
- Role of Pharmacokinetics in Establishing Bioequivalence for Orally Inhaled Drug Products: Workshop Summary ReportJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2011
- Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary ReportJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?Pulmonary Pharmacology & Therapeutics, 2008
- Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug ApplicationsThe AAPS Journal, 2008
- Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDIEuropean Respiratory Journal, 1994
- Determination of the relative bioavailability of salbutamol to the lung following inhalation [see comments]British Journal of Clinical Pharmacology, 1992
- Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.1992
- Aerosol penetration into the lung; influence on airway responses.1981
- The effects of preferential deposition of histamine in the human airway.Published by Elsevier BV ,1978